The courtroom drama between Elon Musk and Sam Altman’s OpenAI isn’t just another celebrity lawsuit. It’s a fight over what OpenAI was supposed to be, what it became as it scaled, and whether the people who steered that transformation did so in a way that matches the organization’s founding promises. In week two of the trial, the testimony has continued to narrow in on a central question that sits beneath almost every exchange: when an AI lab grows from an ambitious nonprofit mission into a high-stakes, capital-intensive enterprise, what exactly counts as “betraying” the mission—and what counts as adapting to reality?
Musk’s position is straightforward in its framing, even if the details are anything but simple. He argues that OpenAI abandoned its original goal of developing AI for the benefit of humanity and shifted toward profit-seeking priorities. In his telling, the organization’s evolution wasn’t merely inevitable growth; it was a change in direction that should have triggered accountability. The lawsuit also seeks remedies that would reach beyond money—Musk is asking the court to remove Altman and Greg Brockman from their roles and to stop OpenAI from operating as a public benefit corporation. He has also demanded damages that, if awarded, would be enormous.
OpenAI’s response is equally direct, but aimed at undermining the premise of the case. OpenAI says the lawsuit is baseless and motivated by competitive jealousy—an attempt to derail a rival. In OpenAI’s view, Musk’s claims are less about governance and mission fidelity and more about positioning his own AI efforts, including xAI and its Grok product, against ChatGPT. That argument matters because it reframes the entire narrative: instead of a principled founder trying to enforce a mission, OpenAI portrays Musk as someone using litigation to gain leverage in a fast-moving market.
What makes the trial especially compelling to watch is that it’s not only about abstract principles. The testimony is repeatedly pulled back to concrete decisions: how OpenAI structured itself, how it handled funding, how it interacted with major partners, and how leadership interpreted the organization’s obligations. Even when witnesses speak in broad terms—about AI risk, about the urgency of building advanced systems, about the meaning of “benefit”— the courtroom is still trying to determine whether specific governance choices were lawful, consistent, and faithful to the organization’s stated purpose.
In the early phase of the proceedings, Musk took the stand as the first witness called. Over multiple days of testimony, he presented his interest in founding OpenAI as a mission-driven effort—something he described in terms of saving humanity. That framing is important because it sets up the moral logic of his case: if the mission was existentially important, then any deviation becomes more than a business disagreement. It becomes a betrayal of a cause.
Musk’s testimony also served another function: it established the emotional and strategic tone of the trial. He wasn’t simply recounting events; he was arguing for interpretation. He portrayed himself as someone who wanted OpenAI to remain aligned with its nonprofit-like ethos, and he suggested that later leadership made choices that moved the organization away from that alignment. The courtroom exchanges around his motivations and recollections have been part of what makes the trial feel like a contest of narratives rather than a dry accounting exercise.
After Musk’s testimony, the trial moved into week two with additional witnesses and a broader set of themes. Professor Stuart Russell testified, bringing the discussion into the realm of AI risk and the kinds of dangers that motivate governance debates. Russell’s presence signaled that the trial isn’t only about corporate structure; it’s also about the stakes of building powerful AI systems. In other words, the mission question is being treated as inseparable from the safety question. If the mission is “benefit humanity,” then what does humanity need most—innovation speed, safety constraints, or both? And who gets to decide the balance?
As week two progressed, OpenAI cofounder Greg Brockman took the stand. Brockman’s testimony has been notable for its mixture of personal recollection and organizational perspective. He described his relationship with Altman and offered a view of how OpenAI’s leadership thought about progress and goals. But the courtroom dynamic also made clear that Brockman’s role isn’t simply to tell a story; it’s to respond to the legal theory that Musk is advancing. When a witness is asked to explain how decisions were made, the answers inevitably become evidence about intent, governance, and whether the organization’s evolution was consistent with its founding commitments.
One of the more striking aspects of the trial coverage has been how often the proceedings return to the mechanics of funding and control. The dispute isn’t only “did OpenAI become more profit-oriented?” It’s “what did the organization promise, what did it do, and what did it communicate to stakeholders along the way?” In a case like this, the details of term sheets, investments, and corporate structures can matter as much as the rhetoric. The courtroom is effectively asking: were the changes communicated honestly, were they justified, and were they consistent with the mission language that Musk says he relied on?
That’s why the trial has also included testimony and discussion around OpenAI’s interactions with major partners. Microsoft’s involvement has been a recurring thread in the broader narrative, and the courtroom has treated it as more than background. Microsoft is scheduled to appear, and the trial’s coverage has already indicated that the Microsoft investment and related discussions are part of what the jury will consider when evaluating whether OpenAI’s governance drifted away from its stated purpose.
Another procedural element that has drawn attention is the question of live audio streaming. The trial has included discussion of whether audio could be streamed publicly, and lawyers raised concerns tied to witness safety. This detail might sound peripheral, but it reflects a real tension in high-profile trials: the public’s desire for transparency versus the legal system’s duty to protect witnesses and ensure testimony can proceed without intimidation. In this case, the safety concern has been linked to the potential threats faced by witnesses and their families, which underscores how personal and high-stakes the conflict has become.
Tuesday’s testimony included Shivon Zilis, a former OpenAI board member who shares four children with Musk. Her appearance highlights how the trial is not only about corporate governance but also about personal relationships and internal communications. The coverage suggests that audio availability on the stream may be limited due to threats. That matters because it affects how the public experiences the trial, but it also signals that the conflict has spilled beyond boardrooms and into the lives of individuals connected to the organization.
The trial’s witness list also points to a broader strategy by both sides. Musk’s side is trying to establish that OpenAI’s leadership made choices that were inconsistent with the mission and that those choices were not merely pragmatic adjustments. OpenAI’s side is trying to show that the lawsuit is a mischaracterization of events and that Musk’s claims are driven by competitive motives rather than governance principles. When you watch the testimony unfold, you can see both strategies at work: one side pushes for mission betrayal; the other side pushes for motive and context.
A key part of Musk’s requested relief is governance-level intervention. He is asking for removal of Altman and Brockman and for OpenAI to stop operating as a public benefit corporation. That’s a dramatic ask because it implies that the court should treat the alleged mission drift as something serious enough to justify structural change. It also implies that the jury’s findings could reshape how OpenAI is governed, regardless of what happens in the broader AI market.
OpenAI’s counter-narrative is designed to make that ask look unreasonable. By calling the lawsuit baseless and jealous, OpenAI is essentially arguing that the court should not treat competitive rivalry as a mission enforcement mechanism. In OpenAI’s framing, Musk’s litigation is a tool to derail a competitor—particularly one that has become central to consumer AI through ChatGPT. That framing is reinforced by the fact that xAI’s Grok is positioned as a competing product. Even if the legal claims are about governance, the jury will inevitably hear about competition, because competition is part of the story of why Musk is suing now.
This is where the trial becomes more than a dispute between two men. It becomes a referendum on how founders and boards should be judged when organizations evolve. Many companies start with ideals and then face the reality of scaling. The legal system, however, doesn’t automatically treat evolution as betrayal. It requires evidence of wrongdoing, breach, or inconsistency with obligations. So the trial is effectively testing whether Musk can prove that OpenAI’s evolution crossed a legal line—not just a moral one.
At the same time, the trial is also testing whether OpenAI’s leadership can convincingly argue that the changes were necessary and consistent with the mission’s spirit. Brockman’s testimony, for example, is likely to be scrutinized for how he describes decision-making and how he frames the organization’s progress. When witnesses say things like OpenAI is moving toward AGI or that certain milestones represent a path to beneficial outcomes, those statements can either support the mission narrative or be used to argue that the mission was replaced by ambition.
The trial coverage indicates that Brockman has discussed OpenAI’s early days and has offered a view of progress toward AGI. That kind of testimony is inherently interpretive. It invites the jury to decide whether “progress” is aligned with “benefit humanity,” or whether it’s simply a justification for shifting priorities. In a case like this, the jury isn’t just evaluating facts; it’s evaluating credibility and coherence.
There’s also a subtle but important theme running through the proceedings: the difference between individual versus systemic risk. AI risk isn’t only about one bad actor or one unsafe model release. It’s about the broader ecosystem—how incentives, governance, and deployment practices interact. The trial’s inclusion of expert testimony on AI risks suggests that the jury will be asked to consider whether OpenAI’s governance choices affected the organization’s ability to manage those risks. If the mission is “benefit humanity,” then safety governance becomes part of what “benefit” means in practice.